Journal article
Reduced Maternal Circulating Cell-Free Mitochondrial DNA Is Associated With the Development of Preeclampsia
Journal of the American Heart Association, Vol.11(2), pp.e021726-e021726
01/18/2022
DOI: 10.1161/JAHA.121.021726
PMCID: PMC9238514
PMID: 35014857
Abstract
Background Circulating cell-free mitochondrial DNA (ccf-mtDNA) is a damage-associated molecular pattern that reflects cell stress responses and tissue damage, but little is known about ccf-mtDNA in preeclampsia. The main objectives of this study were to determine (1) absolute concentrations of ccf-mtDNA in plasma and mitochondrial DNA content in peripheral blood mononuclear cells and (2) forms of ccf-mtDNA transport in blood from women with preeclampsia and healthy controls. In addition, we sought to establish the association between aberrance in circulating DNA-related metrics, including ccf-mtDNA and DNA clearance mechanisms, and the clinical diagnosis of preeclampsia using bootstrapped penalized logistic regression. Methods and Results Absolute concentrations of ccf-mtDNA were reduced in plasma from women with preeclampsia compared with healthy controls (
≤0.02), while mtDNA copy number in peripheral blood mononuclear cells did not differ between groups (
>0.05). While the pattern of reduced ccf-mtDNA in patients with preeclampsia remained, DNA isolation from plasma using membrane lysis buffer resulted in 1000-fold higher ccf-mtDNA concentrations in the preeclampsia group (
=0.0014) and 430-fold higher ccf-mtDNA concentrations in the control group (
<0.0001). Plasma from women with preeclampsia did not induce greater Toll-like receptor-9-induced nuclear factor kappa-light-chain enhancer of activated B cells-dependent responses in human embryonic kidney 293 cells overexpressing the human
gene (
>0.05). Penalized regression analysis showed that women with preeclampsia were more likely to have lower concentrations of ccf-mtDNA as well as higher concentrations of nuclear DNA and DNase I compared with their matched controls. Conclusions Women with preeclampsia have aberrant circulating DNA dynamics, including reduced ccf-mtDNA concentrations and DNA clearance mechanisms, compared with gestational age-matched healthy pregnant women.
Details
- Title: Subtitle
- Reduced Maternal Circulating Cell-Free Mitochondrial DNA Is Associated With the Development of Preeclampsia
- Creators
- Spencer C Cushen - University of North Texas Health Science CenterContessa A Ricci - University of North Texas Health Science CenterJessica L Bradshaw - University of North Texas Health Science CenterTalisa Silzer - University of North Texas Health Science CenterAlexandra Blessing - University of North Texas Health Science CenterJie Sun - University of North Texas Health Science CenterZhengyang Zhou - University of North Texas Health Science CenterSabrina M Scroggins - University of IowaMark K Santillan - Roy J. and Lucille A. Carver College of MedicineDonna A Santillan - Roy J. and Lucille A. Carver College of MedicineNicole R Phillips - University of North Texas Health Science CenterStyliani Goulopoulou - University of North Texas Health Science Center
- Resource Type
- Journal article
- Publication Details
- Journal of the American Heart Association, Vol.11(2), pp.e021726-e021726
- DOI
- 10.1161/JAHA.121.021726
- PMID
- 35014857
- PMCID
- PMC9238514
- NLM abbreviation
- J Am Heart Assoc
- ISSN
- 2047-9980
- eISSN
- 2047-9980
- Grant note
- UL1 TR002537 / NCATS NIH HHS T32 AG020494 / NIA NIH HHS
- Language
- English
- Date published
- 01/18/2022
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9984318322302771
Metrics
25 Record Views